← Back to headlines
GLP-1 Receptor Agonists Show Promise for Dermatological Conditions
New research suggests that GLP-1 receptor agonists, drugs typically used for type 2 diabetes and obesity, may possess anti-inflammatory properties beneficial for patients with dermatological diseases. This finding comes from a summary of current knowledge on their application in dermatology.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
